| Olga Goulko, MD | |
|
2125 Center Ave Ste 200, Fort Lee, NJ 07024-5810 | |
| (201) 461-5655 | |
| (201) 461-1181 |
| Full Name | Olga Goulko |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 43 Years |
| Location | 2125 Center Ave Ste 200, Fort Lee, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710094578 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MA065361 (New Jersey) | Primary |
| Entity Name | Dermatology & Laser Surgery Ctr |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780937045 PECOS PAC ID: 0840425252 Enrollment ID: O20131021000078 |
News Archive
Mitrionics AB, the technology leader in FPGA-based hybrid computing, today announced that the Queensland University of Technology (QUT) High Performance Computing group has selected the Mitrion™ Accelerated Computing Platform to explore several projects designed to accelerate algorithms in different application areas.
New estimates released 9/18/13 from the Office of the Actuary at the Centers for Medicare and Medicaid Services project that aggregate health care spending in the United States will grow at an average annual rate of 5.8 percent for 2012-22, or 1.0 percentage point faster than the expected growth in the gross domestic product.
The November issue of the WHO Bulletin features an editorial examining the need for a new model for pharmaceutical research, a public health news roundup, a research article examining parental perceptions surrounding polio immunization activities in Karachi, Pakistan, and a paper on the use of evidence to support healthy public policy, among others.
Idera Pharmaceuticals, Inc. today presented data showing that IMO-4200, a dual agonist of Toll-like receptor (TLR) 7 and TLR8, in combination with approved cancer treatments, rituximab or bortezomib, significantly increased antitumor activity in several preclinical lymphoma models. The presentation, entitled "Antitumor Activity of an RNA-Based Agonist of TLR7 and 8 in Preclinical Models of Hematological Malignancies," was made at the 52nd Annual Meeting of the American Society for Hematology in Orlando, Florida by Idera scientists.
A new study suggests that frequent binge drinking is associated with insomnia symptoms in older adults.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Olga Goulko, MD 2125 Center Ave Ste 200, Fort Lee, NJ 07024-5810 Ph: (201) 461-5655 | Olga Goulko, MD 2125 Center Ave Ste 200, Fort Lee, NJ 07024-5810 Ph: (201) 461-5655 |
News Archive
Mitrionics AB, the technology leader in FPGA-based hybrid computing, today announced that the Queensland University of Technology (QUT) High Performance Computing group has selected the Mitrion™ Accelerated Computing Platform to explore several projects designed to accelerate algorithms in different application areas.
New estimates released 9/18/13 from the Office of the Actuary at the Centers for Medicare and Medicaid Services project that aggregate health care spending in the United States will grow at an average annual rate of 5.8 percent for 2012-22, or 1.0 percentage point faster than the expected growth in the gross domestic product.
The November issue of the WHO Bulletin features an editorial examining the need for a new model for pharmaceutical research, a public health news roundup, a research article examining parental perceptions surrounding polio immunization activities in Karachi, Pakistan, and a paper on the use of evidence to support healthy public policy, among others.
Idera Pharmaceuticals, Inc. today presented data showing that IMO-4200, a dual agonist of Toll-like receptor (TLR) 7 and TLR8, in combination with approved cancer treatments, rituximab or bortezomib, significantly increased antitumor activity in several preclinical lymphoma models. The presentation, entitled "Antitumor Activity of an RNA-Based Agonist of TLR7 and 8 in Preclinical Models of Hematological Malignancies," was made at the 52nd Annual Meeting of the American Society for Hematology in Orlando, Florida by Idera scientists.
A new study suggests that frequent binge drinking is associated with insomnia symptoms in older adults.
› Verified 8 days ago
Norman Hope Ilowite, DO Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1583 Center Ave, Fort Lee, NJ 07024 Phone: 207-947-2700 |